View more on these topics

Santander pulls out of Williams & Glyn sale


Santander has pulled out of talks with Royal Bank of Scotland to buy more than 300 Williams & Glyn branches, according to the Financial Times.

The talks fell through due to RBS asking for more money than Santander were willing to pay.

Interested bidders are BBVA, Secure Trust and Virgin. The network has been valued at around £2bn.

RBS must sell Williams & Glyn by the end of next year, according to the terms of its state bailout.

Santander made a formal offer for the Williams & Glyn network earlier in the year.

The RBS branches will be rebranded as Williams & Glyn after a sale, creating the UK’s seventh-largest retail bank.

The network would have 1.7 million customers and 2 per cent of the current account market.

Santander first tried to buy Williams & Glyn in 2012.

In April, RBS said it doubted it would sell the network by the end of 2017.

It said that building a separate IT platform for the sell-off is “challenging” and it is trying to find other ways to separate and sell Williams & Glyn.



Challenger bank eyes RBS spin-off Williams & Glyn

Challenger bank Secure Trust is weighing up a bid for Royal Bank of Scotland arm Williams & Glyn, according to City AM. Santander and BBVA are also tipped to bid for Williams & Glyn, which has 300 UK branches. RBS must sell Williams & Glyn by the end of 2017 under the conditions of its […]


Santander and Virgin eye £2bn Williams & Glyn

Santander UK and Virgin Money are preparing to bid for Williams & Glyn, the bank due to be spun out of Royal Bank of Scotland. Sky News reports the two banks are the organisations mentioned in a statement issued today that referred to a “number of informal approaches” for its Williams & Glyn business. The […]

State of the markets: UK equity income

Artemis Income Fund manager Nick Shenton discusses the state of the UK equity income market with journalist Alexis Xydias. With the first three months of 2015 showing strong returns for both the Artemis Income Fund and UK markets generally, Nick Shenton discusses the fund’s top contributors – including overseas holdings Novartis and Bayer – and […]


News and expert analysis straight to your inbox

Sign up


    Leave a comment